MedPath

Comparison of Dry needling versus Injection withlocal anaesthetics in Painful points, known astrigger Points in Myofascial Pain Syndrome in active workingpopulation in West Bengal

Phase 4
Not yet recruiting
Conditions
Myalgia,
Registration Number
CTRI/2019/07/020431
Lead Sponsor
ESI Institute of Pain Management
Brief Summary

This study is a Prospective Randomised study conducted with total 60 patients from OPD of ESI Institute of Pain Management , suffering from upper back Myofascial Pain for more than 3 months and not responding to oral medicines for 2 months and NRS pain score more than 4. They are divided in two groups randomly. Group A consists of 30 patients and they will be treated with 0.25% Bupivacaine and 4 mg dexamethasone with 24 G needle. Group B consists of 30 patients and will be treated only by dry needling with 24 G needle. Injections will be given weekly for 4 injections and NRS pain score will be noted before the 1st injection and after 1 week. Statistical analysis will be done according to appropriate test.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria
  1. Pain more than 3 months 2) Doesn’t relieve with multiple oral medications for last 2 months 4) Intensity of pain more than 4 according to NRS scoring.
Exclusion Criteria
  1. Local trauma 2) Tumour 3) Inflammation 4) Infection 5) On anticoagulant prophylaxis 6) Blood coagulation disorder 7) Pregnancy 8) Psychiatric illness 9) History of allergy to medication used for the study 10) Uncontrolled Diabetes Mellitus.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain in NRS Scorebefore 1st injection and 1 week after the 4th | injection.
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

ESI Hospital, Sealdah

🇮🇳

Kolkata, WEST BENGAL, India

ESI Hospital, Sealdah
🇮🇳Kolkata, WEST BENGAL, India
Dr Subrata Goswami
Principal investigator
09830430430
drsgoswami@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.